Rowe Price funds beat comparable index funds more frequently - and with higher returns - than the average of all active managers. This has meant more money for investors. That's our T. Rowe Price strategic investing difference.

Rowe Price receives the Scope Award 2022 in the category "Best Asset Manager / Equities". Stability and consistent positive performance resulted in T. Rowe Price scoring well in the entire DACH region. More than 70% of the equity funds assessed by Scope received a top rating - some of them over a period of five years.

independent investment management firm T. Rowe Price is an independent investment management firm focused on helping clients meet their objectives and achieve their long-term financial goals.

The Fund seeks to invest common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences. Majority of fund assets are expected to be invested in large- and mid-cap companies.

• Advice Solutions.
• Retirement Advisory Service.
• The ActivePlus Portfolios® Program.
• Private Asset Management.

Our priority is helping our clients - individuals, financial intermediaries, and institutions around the globe - achieve their long-term financial goals via a comprehensive range of exceptional investment options.

Thomas Rowe Price, Jr. Since 1937, we've had one simple goal: to help you achieve yours. Thomas Rowe Price, Jr., our founder, focused on meeting each client's individual needs and emphasizing the importance of their success.

Investment Objective The fund seeks dividend income and long-term capital growth. Performance data quoted represents past performance and does not guarantee future results; current performance may be higher or lower than performance quoted.

Rowe Price Group, Inc. is an American publicly owned global investment management firm that offers funds, subadvisory services, separate account management, and retirement plans and services for individuals, institutions, and financial intermediaries.

It funds basic biomedical research that provides a scientific foundation for the development of new drugs by private industry.

Since 1937, we've had one simple goal: to help you achieve yours. Thomas Rowe Price, Jr., our founder, focused on meeting each client's individual needs and emphasizing the importance of their success.

Our priority is helping our clients - individuals, financial intermediaries, and institutions around the globe - achieve their long-term financial goals via a comprehensive range of exceptional investment options.